MedPath

Danisco Sweeteners Oy

🇫🇮Finland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.daniscosweeteners.com

Clinical Trials

14

Active:0
Completed:10

Trial Phases

3 Phases

Phase 2:1
Phase 3:4
Not Applicable:7

Drug Approvals

1

NMPA:1

Drug Approvals

Fructose

Product Name
果糖氯化钠注射液
Approval Number
H20130688
Approval Date
Oct 9, 2013
NMPA

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (58.3%)
Phase 3
4 (33.3%)
Phase 2
1 (8.3%)

Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.

Phase 2
Completed
Conditions
Constipation
Gastrointestinal Disorder
First Posted Date
2014-07-14
Last Posted Date
2015-05-07
Lead Sponsor
Danisco Sweeteners Oy
Target Recruit Count
228
Registration Number
NCT02189707
Locations
🇫🇷

EUROFINS OPTIMED Clinical Research, Gières, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.